imiquimod has been researched along with Sensitivity and Specificity in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alverdy, AK; Ameer, GA; He, TC; Liu, W; Luo, W; Mostafa, S; Pakvasa, M; Reid, RR; Wolf, JM; Zhao, C | 1 |
| Banzhaf, CA; Jemec, GB; Mogensen, M; Ring, HC; Themstrup, L | 1 |
| Gao, Q; Ge, J; Song, S; Su, Z; Sun, G; Sun, W; Sun, X; Wang, H; Wang, Y; Xie, S; Yi, L; Zhang, B | 1 |
| Battiste, JL; Harrison, LI; Nelson, RJ; Stoesz, JD; Zarraga, IE | 1 |
| Banaei, N; Gaur, RL; Suhosk, MM | 1 |
| Astner, S; Curiel-Lewandrowski, C; Frankenthaler, RA; González, S; Swindells, KJ; Tahan, SR; Williams, CM | 1 |
| Gonik, B; Manlove-Simmons, JM; Svinarich, DM; Tomai, M; Zaher, FM | 1 |
1 trial(s) available for imiquimod and Sensitivity and Specificity
| Article | Year |
|---|---|
Optical coherence tomography imaging of non-melanoma skin cancer undergoing imiquimod therapy.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Melanoma; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, Optical Coherence; Treatment Outcome | 2014 |
6 other study(ies) available for imiquimod and Sensitivity and Specificity
| Article | Year |
|---|---|
Imiquimod Acts Synergistically with BMP9 through the Notch Pathway as an Osteoinductive Agent In Vitro.
Topics: Animals; Cell Differentiation; Cells, Cultured; Gene Expression Regulation; Growth Differentiation Factor 2; Imiquimod; In Vitro Techniques; Mice; Osteogenesis; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity; Signal Transduction | 2019 |
SIRT1 Activation Ameliorates Aldara-Induced Psoriasiform Phenotype and Histology in Mice.
Topics: Aminoquinolines; Animals; Biopsy, Needle; Cell Differentiation; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Imiquimod; Immunohistochemistry; Keratinocytes; Mice; Phenotype; Psoriasis; Sensitivity and Specificity; Sirtuin 1; Transcriptional Activation | 2015 |
A pharmaceutical comparison of different commercially available imiquimod 5% cream products.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Labeling; Drug Stability; Drug-Related Side Effects and Adverse Reactions; Drugs, Generic; Humans; Imiquimod; Ointments; Probability; Sensitivity and Specificity; Structure-Activity Relationship; Therapeutic Equivalency | 2009 |
In vitro immunomodulation of a whole blood IFN-γ release assay enhances T cell responses in subjects with latent tuberculosis infection.
Topics: Adolescent; Adult; Aged; Aminoquinolines; Female; Humans; Imiquimod; Interferon-gamma; Interferon-gamma Release Tests; Latent Tuberculosis; Lipopolysaccharides; Male; Middle Aged; Poly I-C; Reproducibility of Results; Sensitivity and Specificity; T-Lymphocytes; Toll-Like Receptors; Young Adult | 2012 |
Use of in vivo confocal microscopy in malignant melanoma: an aid in diagnosis and assessment of surgical and nonsurgical therapeutic approaches.
Topics: Aminoquinolines; Biopsy, Needle; Facial Neoplasms; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Male; Melanoma; Microscopy, Confocal; Middle Aged; Mohs Surgery; Neoplasm Staging; Risk Assessment; Sampling Studies; Sensitivity and Specificity; Skin; Skin Neoplasms; Treatment Outcome | 2004 |
Effect of imiquimod on cytokine induction in first trimester trophoblasts.
Topics: Aminoquinolines; Cell Line; Cell Survival; Cytokines; Dose-Response Relationship, Drug; Female; Humans; Imiquimod; Interferon Inducers; Pregnancy; Pregnancy Trimester, First; Reverse Transcriptase Polymerase Chain Reaction; RNA; Sensitivity and Specificity; Trophoblasts | 2000 |